JP2017522890A5 - - Google Patents

Download PDF

Info

Publication number
JP2017522890A5
JP2017522890A5 JP2017504814A JP2017504814A JP2017522890A5 JP 2017522890 A5 JP2017522890 A5 JP 2017522890A5 JP 2017504814 A JP2017504814 A JP 2017504814A JP 2017504814 A JP2017504814 A JP 2017504814A JP 2017522890 A5 JP2017522890 A5 JP 2017522890A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
absence
acid sequence
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017504814A
Other languages
English (en)
Japanese (ja)
Other versions
JP6905464B2 (ja
JP2017522890A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/079477 external-priority patent/WO2016015788A1/en
Publication of JP2017522890A publication Critical patent/JP2017522890A/ja
Publication of JP2017522890A5 publication Critical patent/JP2017522890A5/ja
Application granted granted Critical
Publication of JP6905464B2 publication Critical patent/JP6905464B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017504814A 2014-07-28 2014-12-30 上皮増殖因子受容体遺伝子の細胞外ドメインｉｉｉ内の変異 Active JP6905464B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14382288 2014-07-28
EP14382288.0 2014-07-28
PCT/EP2014/079477 WO2016015788A1 (en) 2014-07-28 2014-12-30 Mutations in the extracellular domain iii of epidermal growth factor receptor gene

Publications (3)

Publication Number Publication Date
JP2017522890A JP2017522890A (ja) 2017-08-17
JP2017522890A5 true JP2017522890A5 (cg-RX-API-DMAC10.html) 2018-01-18
JP6905464B2 JP6905464B2 (ja) 2021-07-21

Family

ID=51225482

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017504814A Active JP6905464B2 (ja) 2014-07-28 2014-12-30 上皮増殖因子受容体遺伝子の細胞外ドメインｉｉｉ内の変異

Country Status (8)

Country Link
US (2) US11015225B2 (cg-RX-API-DMAC10.html)
EP (2) EP3174896B1 (cg-RX-API-DMAC10.html)
JP (1) JP6905464B2 (cg-RX-API-DMAC10.html)
CN (1) CN106573967B (cg-RX-API-DMAC10.html)
BR (1) BR112017001474A2 (cg-RX-API-DMAC10.html)
CA (1) CA2954952C (cg-RX-API-DMAC10.html)
ES (1) ES2693080T3 (cg-RX-API-DMAC10.html)
WO (1) WO2016015788A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016112064A2 (en) 2015-01-06 2016-07-14 The Johns Hopkins University Response to egfr blockade
CN111499749B (zh) * 2020-03-13 2021-11-09 浙江大学 一种西妥昔单抗突变体及应用
CN115947823B (zh) * 2022-09-29 2024-05-03 江汉大学 一种用于筛选结合和/或激活egfr的有毒金属的表达蛋白及制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914269A (en) * 1997-04-04 1999-06-22 Isis Pharmaceuticals, Inc. Oligonucleotide inhibition of epidermal growth factor receptor expression
EP2439284B1 (en) * 2004-03-31 2019-05-08 The General Hospital Corporation Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
SG10201605049QA (en) * 2011-05-20 2016-07-28 Fluidigm Corp Nucleic acid encoding reactions
EP2554551A1 (en) * 2011-08-03 2013-02-06 Fundacio Institut mar d'Investigacions Médiques (IMIM) Mutations in the epidermal growth factor receptor gene

Similar Documents

Publication Publication Date Title
CN113912710B (zh) 抗新型冠状病毒n蛋白的单克隆抗体及其应用
RU2408735C2 (ru) Способ предсказания ответа на лечение
JP2015522246A5 (cg-RX-API-DMAC10.html)
MX2024007719A (es) Anticuerpos anti-pd-1 para el tratamiento de tumores.
RU2016136716A (ru) Способы диагностики и лечения воспалительного заболевания кишечника
JP2018536393A5 (cg-RX-API-DMAC10.html)
RU2015112024A (ru) Способы диагностики и лечения воспалительного заболевания кишечника
JP2014239695A5 (cg-RX-API-DMAC10.html)
JP2012143232A5 (cg-RX-API-DMAC10.html)
JP2010516678A5 (cg-RX-API-DMAC10.html)
JP2021500916A5 (cg-RX-API-DMAC10.html)
JP2017511131A5 (cg-RX-API-DMAC10.html)
JP2015530868A5 (cg-RX-API-DMAC10.html)
RU2014118739A (ru) Способы ингибирования роста опухоли путем антагонизирования ил-6 рецептора
PH12015502849A1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
JP2014531584A5 (cg-RX-API-DMAC10.html)
JP2012512389A5 (cg-RX-API-DMAC10.html)
RU2016116773A (ru) Способ выявления опухоли поджелудочной железы, антитела и набор для выявления опухоли поджелудочной железы
RU2014107908A (ru) Мутации в гене рецептора эпидермального фактора роста
FI3916392T3 (fi) Menetelmiä cd19-vasta-ainehoidon terapeuttisen hyödyn ennakoimiseksi potilailla
JP2013539032A5 (cg-RX-API-DMAC10.html)
JP2013536442A5 (cg-RX-API-DMAC10.html)
JP2016526167A5 (cg-RX-API-DMAC10.html)
JP2018515071A5 (cg-RX-API-DMAC10.html)
JP2013543117A5 (cg-RX-API-DMAC10.html)